News

< Back

Grantee in the News: Kim Green Uncovers New Brain Finding in AFAR Funded Study

On April 16, 2014 Neuron Journal published results of 2013 New Investigator in Alzheimer’s Disease grantee Kim Green, PhD’s, groundbreaking study, which was partially funded by AFAR.

Dr. Green’s research examined the role neuroinflammation plays in neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease.

In a study performed on wild mice, Dr. Green removed all of the brain’s main immunity defense cells, microglia, through the use of a molecule inhibitor. Dr. Green and his team found that once the inhibitor was removed a new set of microglia developed out of the brain’s largest pool of stem cells.

This research is significant because it is the first of its kind to successful remove microglia cells without damaging other parts of the brain. Researchers look forward to exploring how the ability to replace all the microglia in aged brains with a younger, and presumably healthier set may affect breakthroughs in neurodegenerative research.

More information on this AFAR funded study can be found here.

Kim Green, PhD, is an Assistant Professor in the Department of Neurobiology and Behavior at the University of California, Irvine.

For the latest information on Alzheimer’s disease research please visit our disease specific InfoAging page.

More Recent News

View All News >
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Grantee in the News: Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Grantee in the News:  Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President